Retina/Vitreous

Top Story

Better anatomical improvements seen with OPT-302 with ranibizumab vs. ranibizumab alone

September 13, 2019

No anti-VEGF rescue injections needed in OPTIC phase 1 trial of ADVM-022

September 12, 2019
An intravitreal dose of ADVM-022, a gene therapy designed for long-term VEGF suppression via the expression of aflibercept, resulted in no anti-VEGF rescue injections…

Alimera expands Iluvien distribution agreement with Horus

September 12, 2019
Alimera Sciences and Horus Pharma have expanded a distribution agreement to allow Horus to introduce Iluvien for diabetic macular edema and noninfectious posterior…
In the Journals

Visual, anatomic gains maintained with Eylea monotherapy for PCV

September 11, 2019
Visual and anatomical gains made with aflibercept monotherapy for polypoidal choroidal vasculopathy were maintained long term, according to a study looking at the…
More Headlines »
Case Report

Lamellar Macular Hole Formation in a Patient With Diabetic CME Treated by Intravitreal Bevacizumab Injections

Ophthalmic Surgery, Lasers and Imaging Retina, Volume 4
Online Only, July 1, 2012
A 49-year-old woman with a diagnosis of diabetic cystoid macular edema in both eyes presented with the appearance of a…
More »
CME

Neovascular Retinal Disease: Examining Emerging Trends in Treatment

This activity is supported by an educational grant from Genentech, Inc.

The integration of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy into management protocols…
More »
Video
Meeting News

VIDEO: Study quantifies benefit of sustained-release implant in DME

August 3, 2019
More »

Better anatomical improvements seen with OPT-302 with ranibizumab vs. ranibizumab alone

September 13, 2019
Patients treated with OPT-302 from Opthea Limited plus ranibizumab demonstrated better anatomical changes over those treated with ranibizumab alone…

No anti-VEGF rescue injections needed in OPTIC phase 1 trial of ADVM-022

September 12, 2019
An intravitreal dose of ADVM-022, a gene therapy designed for long-term VEGF suppression via the expression of aflibercept, resulted in no anti-VEGF…

Alimera expands Iluvien distribution agreement with Horus

September 12, 2019
Alimera Sciences and Horus Pharma have expanded a distribution agreement to allow Horus to introduce Iluvien for diabetic macular edema and…

In the Journals

Visual, anatomic gains maintained with Eylea monotherapy for PCV

September 11, 2019
Visual and anatomical gains made with aflibercept monotherapy for polypoidal choroidal vasculopathy were maintained long term, according to a study…

Meeting News

Euretina allocates funds to research management of submacular hemorrhage in wet AMD

September 10, 2019
PARIS — Partnering with Fight for Sight, the European Society of Retina Specialists will award a 2 million euros grant to a research project…

Wize Pharma licenses Copernicus’ gene therapy technology

September 10, 2019
Wize Pharma has entered into an exclusive license agreement to develop and commercialize products based on non-viral gene therapy technology from…

Oxurion’s plasma kallikrein inhibitor shows positive phase 1 study results

September 9, 2019
Phase 1 study results for THR-149, Oxurion’s plasma kallikrein inhibitor, showed it to be safe and well tolerated with a rapid onset of action…

FDA, European Medicines Agency advance abicipar pegol applications for wet AMD

September 9, 2019
The FDA has accepted a biologics license application and the European Medicines Agency has validated a marketing authorization application for…

ProQR’s retinitis pigmentosa treatment receives fast track designation

September 9, 2019
The FDA has granted fast track designation to QR-1123, an investigational antisense oligonucleotide, ProQR Therapeutics announced in a press release…

Santen microshunt study results lead news of the week

September 7, 2019
Here are some of the past week’s top stories on Healio.com/OSN:

Meeting News

Ocular manifestations often present first in multiple sclerosis

September 6, 2019
COEUR D’ALENE, Idaho — There is a high frequency of ocular manifestations in patients with multiple sclerosis, both at onset and during…

Regenxbio, Clearside enter option and license agreement for SCS Microinjector

September 6, 2019
Regenxbio and Clearside Biomedical announced an option and license agreement that will give Regenxbio exclusive worldwide rights to Clearside’s…

BLOG: Learning how to treat with MicroPulse laser therapy

September 5, 2019
In the right hands, MicroPulse laser therapy from Iridex is safe and effective for the treatment of several retinal diseases. I believe that when…

Meeting News

OpRegen appears well tolerated in dry AMD

September 5, 2019
COEUR D’ALENE, Idaho — In patients with dry age-related macular degeneration, the implantation of human embryonic stem cell-derived…

NHS England to fund Luxturna treatment

September 5, 2019
NHS England will fund Luxturna gene therapy treatment for inherited retinal dystrophies starting in January 2020, according to a press release…

AmEx recalls all lots of bevacizumab

September 4, 2019
All lots of bevacizumab 1.25 mg/0.05 mL 31-gauge injectable and bevacizumab 2.5 mg/0.1 mL Normject TB injectable from Pacifico National, doing…

Point/Counter

Would you implant a multifocal IOL in a patient with age-related macular degeneration?

Ocular Surgery News U.S. Edition, September 10, 2019
Patients with macular degeneration experience great frustration. They are losing their independence and their ability to read. Often they are no…

Meeting NewsVideo

VIDEO: Pearls for performing cataract surgery in patients with diabetes

August 29, 2019
COEUR D’ALENE, Idaho — At the Women in Ophthalmology Summer Symposium, Purnima S. Patel, MD, shares measures she takes when planning…

FDA urges recall of AmEx Pharmacy sterile products

August 28, 2019
Products intended to be sterile made by Pacifico National Inc., doing business as AmEx Pharmacy, should not be used due to quality and sterility…

Career inequality for women in ophthalmic research tops news of the week

August 25, 2019
Here are some of the top stories on Healio.com/OSN from the past week:

More Headlines »